E Fosslien
Impact in
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects
- Biochemistry top 10%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- RNA modifications and cancer 2
- Metabolomics and Mass Spectrometry Studies 2
- TGF-β signaling in diseases 1
- Angiogenesis and VEGF in Cancer 1
-
- Inflammatory mediators and NSAID effects 2
- Co-authors
- Abel L. Robertson (1 shared paper)Rajendra Prasad (1 shared paper)F Musil (2 shared papers)R. Fraser (1 shared paper)Robert W. Wissler (1 shared paper)
- Journals
- Clinical Chemistry (2 papers)Atherosclerosis (2 papers)Journal of Lipid Research (1 paper)Medical Hypotheses (1 paper)PubMed (5 papers)
- Partner nations
- United States
In The Last Decade
E Fosslien
11 papers receiving 649 citations
Peers
Comparison fields: 5 of 94
- Pharmacology 302
- Biochemistry 75
- Cancer Research 83
- Genetics 132
- Psychiatry and Mental health 62
Countries citing papers authored by E Fosslien
This map shows the geographic impact of E Fosslien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Fosslien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Fosslien more than expected).
Fields of papers citing papers by E Fosslien
This network shows the impact of papers produced by E Fosslien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Fosslien. The network helps show where E Fosslien may publish in the future.
Co-authors
The 5 scholars most cited alongside E Fosslien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Molecular pathology of cyclooxygenase-2 in neoplasia. | 2000 | 330 |
| 2 | Mitochondrial medicine--molecular pathology of defective oxidative phosphorylation. | 2001 | 152 |
| 3 | Adverse effects of nonsteroidal anti-inflammatory drugs on the gastrointestinal system. | 1998 | 114 |
| 4 | 1986 | 31 | |
| 5 | 1984 | 20 | |
| 6 | 1972 | 18 | |
| 7 | 2002 | 7 | |
| 8 | 1970 | 5 | |
| 9 | Effect of menstrual cycle on protein expression in human uterine leiomyomas. | 1987 | 3 |
| 10 | [Aging of human aortic intima proteins]. | 1987 | 1 |
| 11 | 1977 | 1 |
About E Fosslien
E Fosslien is a scholar working on Molecular Biology, Pharmacology, Spectroscopy, Psychiatry and Mental health and Oncology, having authored 11 papers that have together received 682 indexed citations. Recurring topics across this work include RNA modifications and cancer (2 papers), Advanced Proteomics Techniques and Applications (2 papers), Metabolomics and Mass Spectrometry Studies (2 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers), Inflammatory mediators and NSAID effects (2 papers), Metabolism and Genetic Disorders (1 paper), TGF-β signaling in diseases (1 paper) and Angiogenesis and VEGF in Cancer (1 paper). The work is most often cited by research in Pharmacology (302 citations), Biochemistry (75 citations), Cancer Research (83 citations), Genetics (132 citations) and Psychiatry and Mental health (62 citations). E Fosslien has collaborated with scholars based in United States. Frequent co-authors include Abel L. Robertson, Rajendra Prasad, F Musil, R. Fraser and Robert W. Wissler. Their work appears in journals such as Clinical Chemistry, Atherosclerosis, Journal of Lipid Research, Medical Hypotheses and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.